7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Fatty Acids Increase GDF15 and Reduce Food Intake Through a GFRAL Signaling Axis

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In contrast to the well-defined biological feedback loops controlling glucose, the mechanisms by which the body responds to changes in fatty acid availability are less clearly defined. Growth differentiating factor 15 (GDF15) suppresses the consumption of diets high in fat but is paradoxically increased in obese mice fed a high-fat diet. Given this interrelationship, we investigated whether diets high in fat could directly increase GDF15 independently of obesity. We found that fatty acids increase GDF15 levels dose dependently, with the greatest response observed with linolenic acid. GDF15 mRNA expression was modestly increased in the gastrointestinal tract; however, kidney GDF15 mRNA was ∼1,000-fold higher and was increased by more than threefold, with subsequent RNAscope analysis showing elevated expression within the cortex and outer medulla. Treatment of wild-type mice with linolenic acid reduced food intake and body mass; however, this effect disappeared in mice lacking the GDF15 receptor GFRAL. An equal caloric load of glucose did not suppress food intake or reduce body mass in either wild-type or GFRAL-knockout mice. These data indicate that fatty acids such as linolenic acid increase GDF15 and suppress food intake through a mechanism requiring GFRAL. These data suggest that a primary physiological function of GDF15 may be as a fatty acid sensor designed to protect cells from fatty acid overload.

          Article Highlights

          • The mechanisms by which the body responds to changes in fatty acid availability are less clearly defined.

          • We investigated whether diets high in fat could directly increase growth differentiating factor 15 (GDF15) independently of obesity.

          • Fatty acids increase GDF15 and reduce food intake through a GFRAL signaling axis.

          • GDF15 is a sensor of fatty acids that may have important implications for explaining increased satiety after consumption of diets high in fat.

          Graphical Abstract

          Related collections

          Most cited references29

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Health Effects of Overweight and Obesity in 195 Countries over 25 Years.

          Background While the rising pandemic of obesity has received significant attention in many countries, the effect of this attention on trends and the disease burden of obesity remains uncertain. Methods We analyzed data from 67.8 million individuals to assess the trends in obesity and overweight prevalence among children and adults between 1980 and 2015. Using the Global Burden of Disease study data and methods, we also quantified the burden of disease related to high body mass index (BMI), by age, sex, cause, and BMI level in 195 countries between 1990 and 2015. Results In 2015, obesity affected 107.7 million (98.7-118.4) children and 603.7 million (588.2- 619.8) adults worldwide. Obesity prevalence has doubled since 1980 in more than 70 countries and continuously increased in most other countries. Although the prevalence of obesity among children has been lower than adults, the rate of increase in childhood obesity in many countries was greater than the rate of increase in adult obesity. High BMI accounted for 4.0 million (2.7- 5.3) deaths globally, nearly 40% of which occurred among non-obese. More than two-thirds of deaths related to high BMI were due to cardiovascular disease. The disease burden of high BMI has increased since 1990; however, the rate of this increase has been attenuated due to decreases in underlying cardiovascular disease death rates. Conclusions The rapid increase in prevalence and disease burden of elevated BMI highlights the need for continued focus on surveillance of BMI and identification, implementation, and evaluation of evidence-based interventions to address this problem.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Once-Weekly Semaglutide in Adults with Overweight or Obesity

            Obesity is a global health challenge with few pharmacologic options. Whether adults with obesity can achieve weight loss with once-weekly semaglutide at a dose of 2.4 mg as an adjunct to lifestyle intervention has not been confirmed.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.

              Obesity is a chronic disease with serious health consequences, but weight loss is difficult to maintain through lifestyle intervention alone. Liraglutide, a glucagon-like peptide-1 analogue, has been shown to have potential benefit for weight management at a once-daily dose of 3.0 mg, injected subcutaneously.
                Bookmark

                Author and article information

                Journal
                Diabetes
                Diabetes
                diabetes
                Diabetes
                American Diabetes Association
                0012-1797
                1939-327X
                January 2024
                17 October 2023
                17 October 2023
                : 73
                : 1
                : 51-56
                Affiliations
                [1 ]Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada
                [2 ]Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
                [3 ]Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada
                Author notes
                Corresponding author: Gregory R. Steinberg, gsteinberg@ 123456mcmaster.ca
                Author information
                https://orcid.org/0000-0001-5425-8275
                Article
                230495
                10.2337/db23-0495
                10784653
                37847913
                e5ac9144-7c7b-4f98-9142-8968138e39ab
                © 2023 by the American Diabetes Association

                Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license.

                History
                : 22 June 2023
                : 01 October 2023
                Funding
                Funded by: Tier 1 Canada Research Chair in Metabolic Diseases;
                Funded by: CIHR Post-Doctoral Fellowship Award;
                Funded by: McMaster Institute for Research on Aging (MIRA);
                Funded by: Canadian Institutes of Health Research, DOI 10.13039/501100000024;
                Award ID: 201709FDN-CEBA-116200
                Funded by: Michael DeGroote Fellowship Award in Basic Biomedical Science;
                Funded by: Diabetes Canada Investigator Award;
                Award ID: DI-5-17-5302-GS
                Funded by: J. Bruce Duncan Endowed Chair in Metabolic Diseases;
                G.R.S. acknowledges the support of a Diabetes Canada Operating Grant (OG-3-22-5645-GS), a Canadian Institutes of Health Research (CIHR) Foundation Grant (201709FDN-CEBA-116200), the Tier 1 Canada Research Chair in Metabolic Diseases, and the J. Bruce Duncan Endowed Chair in Metabolic Diseases. D.W. acknowledges the support of fellowship grants from the McMaster Institute for Research on Aging at McMaster University. L.K.T. acknowledges the support of a CIHR Post-Doctoral Fellowship Award and Michael DeGroote Fellowship Award in Basic Biomedical Science.
                Categories
                Obesity Studies

                Endocrinology & Diabetes
                Endocrinology & Diabetes

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content312

                Cited by3

                Most referenced authors739